CTOs on the Move

The Surgical Company

www.fluido.net

 
The Surgical Company is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.fluido.net
  • 1101 Dove St Ste 175
    Newport Beach, CA USA 92660
  • Phone: 800.646.0553

Executives

Name Title Contact Details

Similar Companies

Wound Healing Solutions

Wound Healing Solutions provides high quality, accessible and research driven wound management services to the patient`s bedside. Serving the long-term care and assisted living communities of New Jersey, Pennsylvania, Delaware, Maryland, Virginia and New York- our wound certified nurse practitioners provide socially responsible wound management.

DOTMED.COM

DOTMED.COM Inc. is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthline Med

Healthline Med is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bard Electrophysiology

Bard Electrophysiology is a Lowell, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

T2 Biosystems

At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.